A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2006
10/19/2006	US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders
10/19/2006	US20060235026 Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/19/2006	US20060235002 Novel physiologically active substance
10/19/2006	US20060234945 Ophthalmic therapeutic composition
10/19/2006	US20060234937 Modulation of angiogenesis
10/19/2006	US20060234922 Remedy for corneal failure
10/19/2006	US20060233796 Method of modulating memory effector T-cells and compositions
10/19/2006	US20060233755 A virus envelope vector encapsulating a hepatocyte growth factor (HGF) gene or its plasmid as an active ingredient; gene therapy for the prevention and treatment of deafness
10/19/2006	DE102005017279A1 Composition (A) with at least two ambient temperatures, useful for glass tampon, comprises a carrier component, and a gas component with specific boiling points
10/18/2006	EP1712232A1 Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
10/18/2006	EP1712230A1 Pharmaceutical composition for xerophthalmia and xerostomia treatment
10/18/2006	EP1711190A1 Agent for treating inflammatory diseases
10/18/2006	EP1711186A1 Slow release steroid composition
10/18/2006	EP1283828B1 Novel polymorph v of torasemide
10/18/2006	EP1214068B1 Ophthalmic fluid
10/18/2006	EP1208196B1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/18/2006	EP1107957B1 Pyrimidine compounds
10/18/2006	CN1849125A Therapeutic agent for ageing macular degeneration
10/18/2006	CN1847229A Novel compounds
10/18/2006	CN1846787A Eye gel and its prepn process
10/18/2006	CN1846718A Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
10/18/2006	CN1846709A Prepn Process of electric ophthalmitis treating eye lotion
10/18/2006	CN1846708A Prepn process of glucose eye lotion
10/18/2006	CN1846704A Eye protecting capsule and dripping agent preparing process
10/18/2006	CN1846700A Slow-released 5-fluorouracil system in vitreous chamber
10/18/2006	CN1279891C Use of water solution containing positive ion cellulose polymer in preparation of drug for treating dry eye
10/18/2006	CN1279844C Nutritional supplement to treat macular degeneration
10/17/2006	US7122679 Multicyclic compounds and the use thereof
10/17/2006	US7122677 NK1 antagonists
10/17/2006	US7122635 Method and composition for angiogenesis inhibition
10/17/2006	US7122579 Eye treatments using synthetic thyroid hormone compositions
10/17/2006	US7122554 Sexual disorders therapy; hypotensive agents; chronic obstructive pulmonary disease; congestive heart failure; asthma; antiallergens
10/17/2006	US7122551 Metalloproteinase inhibitor compounds
10/17/2006	US7122547 Anthranilic acid amides and the use thereof as medicaments
10/17/2006	US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
10/17/2006	US7122539 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications.
10/17/2006	US7122517 Crystallized structure of type IV collagen NC1 domain hexamer
10/17/2006	US7122362 For diagnosing, treating, or preventing disorders associated with aberrant expression of human phosphodiesterases
10/17/2006	US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled
10/17/2006	US7122336 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
10/17/2006	US7122187 Treating autoimmune diseases with humanized anti-CD40L antibody
10/17/2006	US7122181 Gene therapy; eye diseases
10/17/2006	CA2447405C Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
10/12/2006	WO2006107902A2 Use of spirostenols to treat mitochondrial disorders
10/12/2006	WO2006107330A1 Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
10/12/2006	WO2006106915A1 PROTECTIVE AGENT FOR RETINAL NEURONAL CELL CONTAINING PROSTAGLANDIN F2α DERIVATIVE AS ACTIVE INGREDIENT
10/12/2006	WO2006073786A3 Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy
10/12/2006	US20060229346 Method for treating vascular hyperpermeable disease
10/12/2006	US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
10/12/2006	US20060229324 Quinazolin-4-one derivatives
10/12/2006	US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/12/2006	US20060229311 Isatine derivatives with neurotrophic activity
10/12/2006	US20060229301 To treat inflammatory diseases, immune diseases like autoimmune diseases or allergic diseases, or HIV infection; chemokine receptor antagonists; safe and low-toxic; 1-butyl-3-isobutyl-1,3,8-triazaspiro[4.5]decane-2,4-dione
10/12/2006	US20060229239 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis
10/12/2006	US20060228752 Genetic polymorphisms in the preprotachykinin gene
10/12/2006	US20060228394 Ocular solutions
10/12/2006	US20060228393 Ocular solutions
10/12/2006	US20060228306 Combination antihistamine and steroid medication
10/12/2006	CA2605386A1 Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
10/12/2006	CA2603127A1 Use of spirostenols to treat mitochondrial disorders
10/12/2006	CA2602850A1 Ocular delivery of interferon-tau
10/11/2006	EP1710307A2 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
10/11/2006	EP1709965A2 Methods of treating cytokine mediate diseases
10/11/2006	EP1709959A1 Reagent for lacrimation examination and method of lacrimation examination
10/11/2006	EP1708988A1 Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it
10/11/2006	EP1708987A1 L-(-)-moprolol l-(+)-tartrate
10/11/2006	EP1399150A4 Vitamin c compositions
10/11/2006	EP1384998B1 Eyestrain model, method of constructing the same, evaluation method with the use of the model and drugs screened by using the evaluation method
10/11/2006	EP1147134B1 Novel potassium channels and genes encoding these potassium channels
10/11/2006	EP0944619B1 Novel integrin receptor antagonists
10/11/2006	EP0804479B1 Method of treating diabetes mellitus using kgf
10/11/2006	CN1846456A Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone
10/11/2006	CN1845904A Ophthalmic compositions for treating ocular hypertension
10/11/2006	CN1845739A Compositions comprising benzo (G) quinoline derivatives and prostaglandin derivatives
10/11/2006	CN1843503A Eye drops
10/11/2006	CN1843457A Oral liquid for promoting eyesight and protecting eye
10/11/2006	CN1843398A Medicine possessing treating myopia function
10/11/2006	CN1843381A Use of microbe culture in treating and preventing myopia and relieving eye fatigue
10/11/2006	CN1843380A Use of microbe culture in treating and relieving retina pigment denaturation
10/11/2006	CN1843367A Ophthalmic pharmaceutical composition for resisting fungus
10/11/2006	CN1843358A Ketoconazole eye drops and fabricating method thereof
10/11/2006	CN1843342A Eye medicine for treating fungal keratitis
10/11/2006	CN1279054C Type I cytokine receptor TCCR
10/11/2006	CN1279041C Diazabicyclo alkane derivatives with NK1 antagonistic activity
10/11/2006	CN1279040C Tryasolyl tropane derivatives for therapy
10/10/2006	US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
10/10/2006	US7119201 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
10/10/2006	US7119186 Nucleotide sequences coding polypeptide for use in the treatment of spinocerebellar ataxia
10/10/2006	US7119116 Direct aminolysis of a carbamate ester or hydrolysis to an acid followed by coupling with an amine; analgesics, disorders of eating, nervous system, psychology, sleep, urogenital, respiratory and gastrointestinal systems; antiischemic, anticarcinogenic, antiinflammatory agents, antiallergens
10/10/2006	US7119107 Pyridone derivatives
10/10/2006	US7119098 Antitumor agents; osteoporosis; antiarthritic agents; oral diseases
10/10/2006	US7119086 Affinity and selectivity for arginine-vasopressin and/or ocytocin receptors; synthesis
10/10/2006	US7119083 novel 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal
10/10/2006	US7119081 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates
10/10/2006	US7118905 Nucleic acid encoding angiogenesis inhibitor
10/10/2006	US7118770 Plant extracts formed via steam distillation of essential oils
10/10/2006	CA2418778C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
10/10/2006	CA2268799C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
10/10/2006	CA2228393C Use of adamantane derivatives for treating diseases of the inner ear
10/10/2006	CA2152191C Therapeutic agent for glaucoma and ocular hypotensive agent

1 ... 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 ... 531